Market Drivers

Technological Advancements in Imaging Modalities

The market for breast imaging is improved by continuing advances in making images clearer, more accurate and comfortable for patients. More people are using 3D mammography, along with contrast-enhanced mammography (CEM) and MRI with special techniques, because they give a clearer picture of breast tissue. Moreover, imaging machines have advanced further by using AI and machine learning, helping doctors detect cancer faster and more reliably, shorten the time spent on reading images and improve the performance of diagnostics. 3D mammography (Digital Breast Tomosynthesis) has also become common practice. A recent study published in Radiology (2020) found that 3D mammography helps detect more cancers and reduces false positives by 15% compared to regular 2D methods. Imaging tools are now being made smaller to bring them to places that do not have adequate healthcare.

Market Restraints

Barriers to Breast Cancer Screening Program Adoption

For example, some difficulties are making an appointment, not having nearby places to go to, problems with public transportation, especially outside cities and lack of details about screening, some false beliefs about it and unavailable information in other languages. A lack of financial resources, no health insurance and beliefs influenced by culture or religion also prevent people from going for preventive screenings. There aren’t enough specialists such as breast imaging radiologists and sonographers and the areas for breast cancer screenings are not well spaced, so the number of people getting screened goes down and delays in early detection can result.

By Technology

In 2024, Ionizing Breast Imaging captured 34.32% due to the introduction of new breast imaging technologies based on ionizing technology.

Over the next years, more new breast imaging technologies using ionizing technology will be adopted which will allow the segment to grow. Improvements in current ionization based technology are expected to get adequate investment, helping the segment expand throughout the estimated period. In addition, the majority of market players will try to invest more money in technology to create better products for their consumers. Due to efforts for breast cancer detection, the global breast imaging market is seeing more growth in mammography. Recommendations from the United States Preventive Services Task Force about mammography screening. Most people choose the procedure since it is an accurate method of detecting breast cancer. Such benefits support the expansion of the mammography segment.

By End-User

In 2024, Hospitals has market share of 30.62% of market sales with market value of USD 1,361.33 Million.

For the year 2024, Hospitals is responsible for 30.62% of total market sales and its market value is USD 1,361.33 Million. Hospitals made up the biggest portion of the end-use segment in 2022. Having advanced breast imaging facilities in a hospital impacts how long a patient stays, the cost involved, the quality of the care they get and the availability of emergency services. At Parkside Hospital in Wimbledon in September 2019, Hologic’s 3Dmammography system with breast tomosynthesis capacity was installed. This trend, as part of the increase in investment in healthcare facilities around the world, will only facilitate the growth of this market in the projected years ahead. Investing in improved infrastructure and diagnostic equipment has been able to coerce the acquisition of better systems and diagnostic equipment Because of investing, the hospitals can supply adequate health coverage for all treatment services they give. The development in this sector would be positively influenced by the mentioned factors. Typically, larger hospitals have in-house breast imaging centres; however, there can be entry barriers associated with high investments & maintenance intervals, space, and qualified professionals. This can burden hospitals who are seeking to manage incorporated imaging facilities. To minimize this burden and to maximize the reach of their facilities and services, hospitals can team-up with diagnostic imaging centres to provide medical imaging facilities. 

By Product Type

Breast imaging systems currently occupy a major share of the Market during the Forecast Period

Breast imaging systems have become more prominent in use primarily due to the existing demand for early and accurate detection of breast cancers. Governments and healthcare organizations worldwide are increasingly investing in national screening programs, relying on mammography and tomosynthesis using digital breast tomosynthesis (DBT) as the standard. In women over 40 years of age, mammography and tomosynthesis systems detect breast cancers with the highest standard of quality. As an illustration, DBT helps detect more cancers and provides fewer false positives than the usual two-dimensional mammograms. The adoption of artificial intelligence (AI) in imaging systems has greatly increased their ability to make accurate diagnoses and enhance workflows. AI is used to help radiologists in finding lesions early which increases the consistency of detection and this is highly useful in today’s crowded healthcare systems. Because of these advances, more hospitals and diagnostic centers are purchasing advanced imaging equipment.

By Geography

North America dominates the Breast Imaging market with estimated market value of USD 1,710.55 Million in 2024, and is expected to reach USD 3,592.05 Million in 2032.

North America's lead in the breast imaging market. The region has a healthcare infrastructure that is advanced and developed, ensuring access to advanced imaging technologies, including access to upfront costs and resources. It has a wide variety of facilities that offer imaging services available to women, including but not limited to hospitals, diagnostic imaging centres, medical offices, and breast centres, all utilising advanced breast medical imaging systems. There is a high incidence of breast cancer in North America, particularly in the United States, so the potential for demand in screening, biopsy, planning (surgery, treatment, follow-up care, etc.), and even research will expand more rapidly than in other regions. Organisations like the American Cancer Society endorse mammograms being done regularly starting at the age of 40, directly correlating to consistent demand for breast-related procedures overall.

Top Players

• Dilon Technologies Inc.
• Fujifilm Holdings Corporation
• Gamma Medica Inc.
• General Electric Company
• Hologic Inc.
• Koning Corporation
• Koninklijke Philips N.V.
• Siemens Ag
• Sonocin Inc.
• Toshiba Corporation
• Others

Key Industry Developments

• In May 2022, QUSTom (Quantitative Ultrasound Stochastic Tomography), a new European project, was coordinated by the Barcelona Supercomputing Centre (BSC). The project is looking to establish a new method for medical imaging that uses both ultrasound and supercomputing to replace or support mammograms and other X-ray-based techniques.

• In June 2022, GE Healthcare allied with the National Cancer Centre Singapore (NCCS). Everyone’s target is to develop more customised care for cancer patients and allow medical staff to access important clinical evidence throughout the patient’s path using artificial intelligence and natural language processing.

• In November 2020, Densitas, Inc. collaborated with Mammography Educators, LLC. The development aims to create an artificial intelligence-powered telehealth technician training platform that would help mammography clinics retain business continuity.

Table of Contents

1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. MARKET INTRODUCTION
   2. MARKET DRIVERS
   3. MARKET RESTRAINTS
   4. FUTURE OPPORTUNITIES
   5. MARKET TRENDS
   6. PORTER’S FIVE FORCES ANALYSIS
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Suppliers
      4. Bargaining Power of Buyers
      5. Intensity of Competitive Rivalry
   7. VALUE CHAIN & PROFIT MARGIN ANALYSIS
   8. PRICING ANALYSIS
   9. REGULATORY FRAMEWORK
   10. COVID-19 IMPACT ANALYSIS
   11. PRODUCT LIFE CYCLE ANALYSIS
   12. PESTLE ANALYSIS
   13. MICRO ECONOMIC ANALYSIS
   14. Market Premium Insights (Enterprise license)
       • Consumer Analysis (List of Potential Consumers)
       • Top 10 Country-Wise Import & Export Data (If Applicable)
       • Regulatory Bodies & Authorization Across the Globe
       • Key Conferences & Events: Next Two Years
       • Top Patents for The Market
5. GLOBAL BREAST IMAGING MARKET REVENUE & SHARE ANALYSIS (2023-2032)
   1. By Technology
      1. Ionizing Breast Imaging Technologies
      2. Non-Ionizing Breast Imaging Technologies
   2. By Product
      1. Breast Imaging Systems
      2. Software & Services
      3. Accessories
   3. By End-User
      1. Hospitals
      2. Diagnostic Imaging Centers
      3. Ambulatory Surgical Centers
6. GLOBAL BREAST IMAGING MARKET REVENUE & SHARE ANALYSIS (2023-2032), BY REGION
   1. NORTH AMERICA 
      1. U.S.
      2. Canada
      3. Mexico
   2. EUROPE
      1. Germany
      2. UK
      3. France
      4. Italy
      5. Spain
      6. Rest of Europe
   3. ASIA PACIFIC 
      1. China
      2. Japan
      3. India
      4. South Korea
      5. Rest of APAC
   4. MIDDLE EAST & AFRICA
      1. GCC
      2. South Africa
      3. Rest of MEA
   5. LATIN AMERICA
      1. Brazil
      2. Argentina
      3. Rest of LATAM

For all the segments and sub-segments, Qualitative as well as Quantitative data will be provided. In Quantitative we provide the historic (2023), base (2024), estimated (2025) and forecasted (2025-2032) market value in USD Million, Share in % with a CAGR (2025-2032). This data would be provided on a regional as well as country level.

1. COMPETITIVE LANDSCAPE
   1. OVERVIEW
   2. KEY PLAYERS MARKET SHARE ANALYSIS
   3. LIST OF KEY STRATEGIC DEVELOPMENTS 
2. COMPANY PROFILES
   1. Dilon Technologies Inc.
      1. Company Overview
      2. Company Financial Insights (Total Revenue, Revenue By Business Segments, and By Region)
      3. Product Benchmarking
      4. Key Strategic Developments (Merges & Acquisitions, Partnership /Agreements/Joint Venture, Expansion, New Product Launches, and other developments)
      5. Business Strategic Overview
      6. SWOT Analysis
   2. Fujifilm Holdings Corporation
   3. Gamma Medica Inc.
   4. General Electric Company
   5. Hologic Inc.
   6. Koning Corporation
   7. Koninklijke Philips N.V.
   8. Siemens Ag
   9. Sonocin Inc.
   10. Toshiba Corporation
   11. OTHERS
3. LIST OF SOURCES
4. DISCLAIMER